Sensei Biotherapeutics, Inc. (SNSE) Tops Q3 EPS by 2c
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) reported Q3 EPS of ($0.29), $0.02 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Sensei Biotherapeutics, Inc. (SNSE) click here.
